---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-027959"
form_type: "8-K"
ticker: "YCBD"
cik: "0001644903"
company_name: "cbdMD, Inc."
filed_at: "2024-08-29T23:59:59+00:00"
generated_at: "2026-05-31T06:59:38.508230+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# cbdMD acquires 'CBD MD' trademark from Majik Medicine for cash/stock; settles litigation

## Summary
- Paid $100k cash on closing; will pay $50k annually for 4 years ($300k total) and issued 75k shares of common stock (50k more in year 2).
- Entered 5-year consulting agreement with Majik; 15% commission on net sales increase from new wholesale customer base of licensed practitioners.
- Amendment to existing convertible notes and security agreement allows pledge of new trademark as permitted lien and payments as permitted indebtedness.
- Majik appointed board member William Raines III as proxy for the initial shares for 12 months.
- Company expects mark enhances IP portfolio and removes TTAB procedural impediments, avoiding continued litigation.

## SEC filing metadata
- accession: 0001437749-24-027959
- form_type: 8-K
- ticker: YCBD
- cik: 0001644903
- company_name: cbdMD, Inc.
- filed_at: 2024-08-29T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644903/000143774924027959/0001437749-24-027959-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644903/000143774924027959/ycbd20240823_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-027959
- JSON: https://secwatch.observer/filing/0001437749-24-027959.json
- Plain text: https://secwatch.observer/filing/0001437749-24-027959.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.